logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Calicheamicin CAS 108212-75-5

Calicheamicin CAS 108212-75-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 108212-75-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
108212-75-5
Appearance::
White To Yellow Solid
Molecular Formula::
C55H74IN3O21S4
Molecular Weight::
1368.35000
EINECS NO::
813-745-9
MDL NO::
NA
CAS NO::
108212-75-5
Appearance::
White To Yellow Solid
Molecular Formula::
C55H74IN3O21S4
Molecular Weight::
1368.35000
EINECS NO::
813-745-9
MDL NO::
NA
Calicheamicin CAS 108212-75-5

Product Description:

Product Name: Calicheamicin CAS NO: 108212-75-5

 

 

Synonyms:

calicheamicin gamma1(I);

Calicheamicin γ1I;

Calicheamicin Gamma1;

 

 

Chemical & Physical Properties:

Appearance: White to yellow solid

Assay :≥99.0%

Density: 1.57±0.1 g/cm3(Predicted)

Alpha: D26 -124° (c = 0.98%, EtOH)

Pka: 7.13±0.60(Predicted)

 

 

The calicheamicins are a class of enediyne antitumor antibiotics derived from the bacterium Micromonospora echinospora, with calicheamicin γ1 being the most notable. It was isolated originally in the mid-1980s from the chalky soil, or "calichi pits", located in Kerrville, Texas. The sample was collected by a scientist working for Lederle Labs. It is extremely toxic to all cells and, in 2000, a CD33 antigen-targeted immunoconjugate N-acetyl dimethyl hydrazide calicheamicin was developed and marketed as targeted therapy against the non-solid tumor cancer acute myeloid leukemia (AML). Calicheamicin γ1 and the related enediyne esperamicin are the two of the most potent antitumor agents known.

Calicheamicins are a series of enediyne antitumor antibiotics originally isolated from the bacterium Micromonospora echinospora. They exert high cytotoxicity and have been applied in tumor therapies for over a decade-- a CD33 antigen-targeted immuno-conjugate: N-acetyl dimethyl hydrazide calicheamicin, was developed as a targeted therapy for non-solid tumor cancer acute myeloid leukemia (AML). Calicheamicin has several derivatives with different chemical modifications, among which γ1 is the most well-characterized. Calicheamicin γ1 contains an aglycon consisting of a bicycle tridec-9-ene-2,6-diyne system with a labile methyl trisulfide group and an aryltetrasaccharide chain. Calicheamicins also contain enediyne moieties that are structurally similar to other enediynes, such as esperamicins, neocarzinostatin, and kedarcidin, etc. After reduction by cellular thiols, the calicheamicin enediyne moieties rearrange to produce a 1, 4-benzenoid diradical.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.